Dr. Benjamin Newell Breyer, MD

Dr. Breyer practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Breyer's NPI, 1316160211, was assigned on April 10, 2007. Dr. Breyer graduated from Pritzker School of Medicine in 2003. Dr. Breyer holds California license A91487.

Dr. Breyer's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Breyer's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Breyer is also affiliated with Zuckerberg San Francisco General Hospital and Trauma Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Breyer to 1 more hospital, 4 group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Breyer practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Breyer's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Breyer is board certified in urology by the American Board of Urology. Dr. Breyer is licensed in California.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Breyer treats.

CMS data shows 1,139 Medicare services from Dr. Breyer across 20 procedure codes in 2024, for 413 Medicare patients. Medicare paid $79,874 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 413 Medicare patients who saw Dr. Breyer in 2024. The largest group is 75 to 84, with 176 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Breyer's median patient age at 72, with 2% women.

In 2024, Dr. Breyer wrote 367 Medicare Part D claims for 169 patients. 78% of them were for generic drugs. CMS names the drug for 284 of them, across 8 drugs with 11 or more claims each, at $64,072 in total drug cost. In 2023, CMS named 427 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Breyer for performance year 2024, reported as part of a group. Dr. Breyer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Breyer as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 340 papers to Dr. Breyer, published from 2001 to 2025. 2022 was the busiest year, with 31. The most frequent topics are Urethral Stricture, Urethra and Urologic Surgical Procedures, Male. Dr. Breyer has published most often in Urology. Dr. Breyer's most frequent co-authors are Bradley A. Erickson, MD, Jill C. Buckley, MD and Lindsay Ann Hampson, MD.

Dmand AI links Dr. Breyer to 2 clinical trials. Conditions studied include Prostatic Neoplasms, Urinary Incontinence, Stress and Prostatic Diseases. University of California, San Francisco sponsors the most, 2.

CMS Open Payments shows 66 general payments to Dr. Breyer from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. Boston Scientific Corporation paid the most, $14,217.

Dr. Breyer graduated from Pritzker School of Medicine in 2003.

Dr. Breyer is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.